Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 12

FROM Techniques and Innovations in Gastrointestinal EndoscopyRandomized Double-blind Sham-controlled Trial of a Novel Silicone-filled Endoscopically Placed Device for Weight LossVolume 26, Issue 1P21-292024This research details a randomized, double-blind, sham-controlled trialinvestigating a novel, endoscopically placed intragastric device called the TransPyloric Shuttle for treating Class I and II obesity, a widespread condition contributing to significant health problems and costs. The study, involving 270 patients, measured the device's effectiveness using the co-primary endpoints of percent total body weight loss (%TBWL) and the proportion of patients achieving at least 5% weight loss after one year. Notably, the treatment group demonstrated a mean %TBWL of 9.5%, significantly outperforming the sham group's 2.8%, and also experienced improvement in cardiometabolic outcomes like reduced blood pressure and cholesterol. The conclusion confirms that this innovative endoscopic device successfully facilitates meaningful weight loss and better health indicators for patients struggling with obesity.